Bioequivalence of a thiomersal-free Hepavax-Gene vaccine

Trial Profile

Bioequivalence of a thiomersal-free Hepavax-Gene vaccine

Phase of Trial: Phase III

Latest Information Update: 30 Nov 2015

At a glance

  • Drugs Hepatitis B vaccine recombinant (Primary)
  • Indications Hepatitis B
  • Focus Adverse reactions; Pharmacodynamics; Therapeutic Use
  • Sponsors Crucell
  • Most Recent Events

    • 30 Nov 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top